Delivery Order SPE2DB20D1100-SPE2DB24FB7U6

Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.1 mg tablets, with a ceiling value of $9,648.11 and a completion date of December 19, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of clonidine HCL ER 0.1 mg tablets in 60-count packages. The $20,024.68 firm fixed-price contract has a completion date of March 12, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, serving as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,563,515,852 units of Clonidine HCL ER 0.1 mg Tablets in 60-count packages. The contract has a ceiling value of $2,293.67 and is a Firm Fixed Price Delivery Order with a completion date of February 2, 2024. The contract is not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,040.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.1 mg tablets, a medication used in the treatment of various medical conditions. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.17 MG Tablets in 30-count packages, with a ceiling value of $1,081.95 and a period of performance through April 16, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,840.10, is for the delivery of CLONIDINE HCL ER 0.1 MG TABLET 60S. This is a firm fixed-price delivery order contract with an ultimate completion date of November 24, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.84 firm fixed-price delivery order is for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a medication used to treat high blood pressure and other medical conditions. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Clonidine HCL ER 0.1 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,415.58 firm fixed price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corporation, as a child award under the company's Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999. The contract has an ultimate completion date of October 15, 2024 and does not utilize a small business set-aside. As a...
This federal contract award is for the delivery of Clonidine HCL ER 0.1 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,365.61 and a completion date of April 3, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,902.41 firm fixed-price delivery order is for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a generic pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB7U6
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,660.23, is for the delivery of Clonidine HCL ER 0.1 mg tablets in quantities of 60s. The award does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/16/25, 12:08 PM